Department of Pathology, Third Faculty of Medicine, Charles University and University Hospital Kralovske Vinohrady, Prague, Czechia.
Pathol Oncol Res. 2022 Apr 29;28:1610156. doi: 10.3389/pore.2022.1610156. eCollection 2022.
Replicative senescence is irreversible cell proliferation arrest for somatic cells which can be circumvented in cancers. Cellular senescence is a process, which may play two opposite roles. On the one hand, this is a natural protection of somatic cells against unlimited proliferation and malignant transformation. On the other hand, cellular secretion caused by senescence can stimulate inflammation and proliferation of adjacent cells that may promote malignancy. The main genes controlling the senescence pathways are also well known as tumor suppressors. Almost 140 genes regulate both cellular senescence and cancer pathways. About two thirds of these genes (64%) are regulated by microRNAs. Senescence-associated miRNAs can stimulate cancer progression or act as tumor suppressors. Here we review the role playing by senescence-associated miRNAs in development, diagnostics and treatment of pancreatic cancer.
复制性衰老(Replicative senescence)是体细胞不可逆的增殖停滞,而这种停滞在癌症中可以被规避。细胞衰老(cellular senescence)是一种过程,它可能发挥两种相反的作用。一方面,这是体细胞对无限增殖和恶性转化的一种自然保护。另一方面,衰老引起的细胞分泌可以刺激相邻细胞的炎症和增殖,从而可能促进恶性肿瘤的发生。控制衰老途径的主要基因也被称为肿瘤抑制基因。几乎有 140 个基因同时调控细胞衰老和癌症途径。这些基因中约有三分之二(64%)受到 microRNAs 的调控。与衰老相关的 microRNAs 可以刺激癌症的进展,或者作为肿瘤抑制因子发挥作用。在这里,我们回顾了与衰老相关的 microRNAs 在胰腺癌的发展、诊断和治疗中的作用。